Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in two major investor conferences in December 2024. The company will present at the Evercore ISI HealthCONx Conference on December 4 at 9:10 a.m. ET and the Citi Global Healthcare Conference on December 5 at 1:00 p.m. ET. Both fireside chat sessions will be available via webcast on the company's website under the 'Events and Presentations' page, with replays accessible for approximately 90 days after the events.
Apellis Pharmaceuticals (Nasdaq: APLS) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel dicembre 2024. L'azienda presenterà alla Evercore ISI HealthCONx Conference il 4 dicembre alle 9:10 a.m. ET e alla Citi Global Healthcare Conference il 5 dicembre alle 1:00 p.m. ET. Entrambi i dibattiti saranno disponibili in diretta streaming sul sito web dell'azienda nella sezione 'Eventi e Presentazioni', con registrazioni accessibili per circa 90 giorni dopo gli eventi.
Apellis Pharmaceuticals (Nasdaq: APLS) ha anunciado su participación en dos grandes conferencias de inversores en diciembre de 2024. La compañía presentará en la Evercore ISI HealthCONx Conference el 4 de diciembre a las 9:10 a.m. ET y en la Citi Global Healthcare Conference el 5 de diciembre a la 1:00 p.m. ET. Ambas sesiones de charla estarán disponibles a través de webcasts en el sitio web de la compañía en la página de 'Eventos y Presentaciones', con repeticiones accesibles durante aproximadamente 90 días después de los eventos.
Apellis Pharmaceuticals (Nasdaq: APLS)는 2024년 12월에 열리는 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 회사는 12월 4일 오전 9시 10분 ET에 Evercore ISI HealthCONx Conference에서 발표하고, 12월 5일 오후 1시에 Citi Global Healthcare Conference에서 발표할 예정입니다. 두 세션은 회사 웹사이트의 '이벤트 및 발표' 페이지를 통해 웹캐스트로 제공되며, 행사 후 약 90일 동안 다시 보기가 가능합니다.
Apellis Pharmaceuticals (Nasdaq: APLS) a annoncé sa participation à deux grandes conférences pour investisseurs en décembre 2024. La société présentera à la Evercore ISI HealthCONx Conference le 4 décembre à 9h10 ET et à la Citi Global Healthcare Conference le 5 décembre à 13h00 ET. Les deux sessions de discussion seront disponibles en webdiffusion sur le site web de l'entreprise dans la section 'Événements et présentations', avec des rediffusions accessibles pendant environ 90 jours après les événements.
Apellis Pharmaceuticals (Nasdaq: APLS) hat seine Teilnahme an zwei großen Investorenkonferenzen im Dezember 2024 angekündigt. Das Unternehmen wird am 4. Dezember um 9:10 Uhr ET auf der Evercore ISI HealthCONx Conference präsentieren und am 5. Dezember um 13:00 Uhr ET auf der Citi Global Healthcare Conference. Beide Fachgespräche werden über einen Webcast auf der Website des Unternehmens unter der Rubrik 'Veranstaltungen und Präsentationen' verfügbar sein, mit Wiederholungen, die etwa 90 Tage nach den Veranstaltungen zugänglich sind.
- None.
- None.
WALTHAM, Mass., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced that the company will participate in the following December investor conferences:
- Evercore ISI HealthCONx Conference: Fireside chat on Wednesday, December 4, 2024, at 9:10 a.m. ET
- Citi Global Healthcare Conference: Fireside chat on Thursday, December 5, 2024, at 1:00 p.m. ET
The live conference webcasts will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.
Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178
FAQ
When is Apellis Pharmaceuticals (APLS) presenting at the Evercore ISI HealthCONx Conference in December 2024?
What time is Apellis Pharmaceuticals (APLS) presenting at the Citi Global Healthcare Conference in December 2024?
How long will the webcasts of Apellis Pharmaceuticals (APLS) December 2024 investor conferences be available?
Where can I watch Apellis Pharmaceuticals (APLS) December 2024 investor conference presentations?
